LSV Asset Management
AMRI

LSV Asset Management’s Albany Molecular Research Inc AMRI Stock Holding History

LSV Asset Management’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-116,427
Closed -$1.17M – 885
2013
Q4 		$1.17M Buy
+116,427
New +$1.41M ﹤0.01% 639

Other funds holding AMRI

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
EWM
Evercore Wealth Management New York $7.07B AUM 24.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
ACM
American Capital Management New York $2.23B AUM 28.03% 1-Year Est. Return

LSV Asset Management's AMRI Position: Q1 2014 in Review

LSV Asset Management sold out of Albany Molecular Research Inc (AMRI) in Q1 2014, closing a stake of 116,427 shares — an estimated $1.17M sold.

LSV Asset Management first reported a position in AMRI in Q4 2013 and held it in 1 quarter. The position peaked at $1.17M in Q4 2013. 113 funds tracked by Wall St. Rank hold AMRI as of Q1 2014.

  • LSV Asset Management reported no remaining Albany Molecular Research Inc position as of Q1 2014 after selling out during the quarter.
  • LSV Asset Management sold 116,427 Albany Molecular Research Inc shares in Q1 2014, an estimated $1.17M.
  • LSV Asset Management first reported a position in Albany Molecular Research Inc in Q4 2013 and held it in 1 quarter.
  • LSV Asset Management's Albany Molecular Research Inc position peaked at $1.17M in Q4 2013.
  • 113 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q1 2014.

Based on LSV Asset Management's 13F filing for Q1 2014, filed 29 Apr 2014.